peter attia tirzepatide 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - The Drive In this episode (#337) of

Zepbound: 2,684% Growth in Its First Full Year on Market Zepbound launched in November 2023 and achieved 2,684% year-over-year revenue growth in its first full year (2024) the fastest launch in obesity drug history

Other GLP-1 Agonists: They work in a similar way

Phentermine is a stimulant-based appetite suppressant that works through different mechanisms than semaglutide

#guthealth #letschat #bedtimeroutine A day of eating (high protein meals & snacks) I started my GLP-1 journey with Tirzepatide 2.5 mg on April 22, 2025

Every concentration, every dose level, every syringe size, mapped out in clear charts you can reference before each injection